Supplemental Perioperative Oxygen to Reduce the Incidence of Post-cesarean Wound Infection

NCT ID: NCT01340534

Last Updated: 2015-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

370 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if the use of supplemental oxygen at 80% FIO2 can reduce the incidence of surgical site infection after emergency cesarean section.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Surgical site infection (SSI) is one of the most important complications that can develop after a cesarean section. SSI can be mild or it can develop into septic shock and death, being cesarean section the most important cause of puerperal infections. Supplemental oxygen at high doses has been advocated as a protective factor for SSI. The purpose of this study is to determine if the use of oxygen at high doses (80% FIO2)can reduce the incidence of SSI after emergency cesarean section.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Wound Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oxygen 80% FIO2

Group of 181 patients that will receive supplemental oxygen 80% FIO2 during surgery (cesarean) and two hours after the procedure.

Group Type EXPERIMENTAL

Supplemental oxygen 80% FIO2

Intervention Type DEVICE

Use of oxygen 80% FIO2 during surgery and 2 hours after the procedure. For this purpose an oxygen mask with reservoir will be used (to guarantee the supply of 80% oxygen during and after surgery)

Use of air (no oxygen during surgery)

Group of 181 patients that will not receive supplemental oxygen during surgery (cesarean).

Group Type PLACEBO_COMPARATOR

Use of air (no oxygen during surgery)

Intervention Type PROCEDURE

No use of oxygen during surgery or in the 2 hours after the procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supplemental oxygen 80% FIO2

Use of oxygen 80% FIO2 during surgery and 2 hours after the procedure. For this purpose an oxygen mask with reservoir will be used (to guarantee the supply of 80% oxygen during and after surgery)

Intervention Type DEVICE

Use of air (no oxygen during surgery)

No use of oxygen during surgery or in the 2 hours after the procedure.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

High dose oxygen No oxygen

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age \> 37 weeks
* Emergency cesarean section
* Regional Anesthesia

Exclusion Criteria

* Elective cesarean section
* Fever of unknown origin at admission
* Twin pregnancy
* Chorioamnionitis
* Acute fetal distress that requires general anesthesia
* Immunocompromise
* Maternal Lung/Respiratory Disease
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saint Thomas Hospital, Panama

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Osvaldo A. Reyes T.

Coordinator of Development and Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bleixen Admadé, Resident

Role: PRINCIPAL_INVESTIGATOR

Saint Thomas Maternity Hospital

Osvaldo A Reyes, MD

Role: PRINCIPAL_INVESTIGATOR

Saint Thomas Maternity Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saint Thomas Maternity Hospital

Panama City, Provincia de Panamá, Panama

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Panama

References

Explore related publications, articles, or registry entries linked to this study.

Bleixen Admadé and Osvaldo Reyes, "Supplemental Perioperative Oxygen (80% FIO2) for the Prevention of Surgical Site Infection after Emergency Cesarean Section," ISRN Infectious Diseases, vol. 2013, Article ID 526163, 4 pages, 2013. doi:10.5402/2013/526163

Reference Type RESULT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MHST2011-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PreOxygenation In RSI Anesthesia
NCT02794532 COMPLETED NA